These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17898830)

  • 41. Active tuberculosis case finding: why, when and how?
    Borgdorff MW; Yew WW; Marks G
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):285. PubMed ID: 23407215
    [No Abstract]   [Full Text] [Related]  

  • 42. A school and community outbreak of tuberculosis in Palmerston North, New Zealand.
    Calder L; Rivers J; Hayhurst M; Brown J; Forde A; Gallagher L; O'Connor P
    N Z Med J; 2008 Jul; 121(1278):50-61. PubMed ID: 18670474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tuberculosis in HIV positive individuals].
    Balcells M ME
    Rev Chilena Infectol; 2009 Apr; 26(2):126-34. PubMed ID: 19621143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tuberculosis screening in a dialysis program.
    Ballantine L
    Nephrol Nurs J; 2000 Oct; 27(5):489-99; quiz 500-1. PubMed ID: 16649324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controlling tuberculosis: we can't do it if we don't find the cases.
    Enarson DA
    East Mediterr Health J; 2003 Jul; 9(4):509-17. PubMed ID: 15748048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The treatment of patients with TB and the role of the nurse.
    Bell C
    Nurs Times; 2004 Sep 7-13; 100(36):48-50. PubMed ID: 15478839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Five "W" in tuberculosis contact tracing: why, when, who, where, and what?].
    Jurcev Savicević A
    Lijec Vjesn; 2011; 133(1-2):65-8. PubMed ID: 21644281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of extensively drug-resistant tuberculosis and role of the pharmacist.
    Mitrzyk BM
    Pharmacotherapy; 2008 Oct; 28(10):1243-54. PubMed ID: 18823220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring tuberculosis patients' adherence to treatment regimens and prevention programs at a public health site.
    Naidoo P; Dick J; Cooper D
    Qual Health Res; 2009 Jan; 19(1):55-70. PubMed ID: 18997153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effects of prophylaxis on QuantiFERON TB-2G responses among children].
    Higuchi K; Okada K; Harada N; Mori T
    Kekkaku; 2008 Sep; 83(9):603-9. PubMed ID: 18979994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tuberculosis: an overview.
    Cruz-Knight W; Blake-Gumbs L
    Prim Care; 2013 Sep; 40(3):743-56. PubMed ID: 23958367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Latent tuberculosis infection, its treatment, and the control and elimination of tuberculosis.
    Enarson DA
    Isr Med Assoc J; 2002 Jan; 4(1):31-2. PubMed ID: 11802307
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of pulmonary tuberculosis].
    Boldú J; Cebollero P; Abu J; De Prado A
    An Sist Sanit Navar; 2007; 30 Suppl 2():99-115. PubMed ID: 17898831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early and late tuberculosis risks among close contacts in Hong Kong.
    Lee MS; Leung CC; Kam KM; Wong MY; Leung MC; Tam CM; Leung EC
    Int J Tuberc Lung Dis; 2008 Mar; 12(3):281-7. PubMed ID: 18284833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Limited benefit of CT scans in tuberculosis contact tracing.
    Yoshiyama T; Kurosaki A; Ogata H; Sasaki Y; Okumura M
    J Infect Chemother; 2019 Oct; 25(10):764-768. PubMed ID: 31101527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recommendations on modern contact investigation methods for enhancing tuberculosis control.
    Cook VJ; Shah L; Gardy J; Bourgeois AC
    Int J Tuberc Lung Dis; 2012; 16(3):297-305. PubMed ID: 22136695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Programmatic approaches to screening for active tuberculosis.
    Uplekar M; Creswell J; Ottmani SE; Weil D; Sahu S; Lönnroth K
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1248-56. PubMed ID: 24025375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose-response relationship between treatment delay of smear-positive tuberculosis patients and intra-household transmission: a cross-sectional study.
    Lin X; Chongsuvivatwong V; Lin L; Geater A; Lijuan R
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):797-804. PubMed ID: 18513768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strong general health care systems: a prerequisite to reach global tuberculosis control targets.
    Mahendradhata Y; Lambert ML; Van Deun A; Matthys F; Boelaert M; van der Stuyft P
    Int J Health Plann Manage; 2003; 18 Suppl 1():S53-65. PubMed ID: 14661941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis.
    Higuchi K; Harada N; Mori T
    Respirology; 2008 May; 13(3):468-72. PubMed ID: 18399875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.